Integral Developments
Substacknewsletter · by Egan Peltan · English
Integral Developments covers the origins of medical innovation and highlights present unmet medical needs
- Audience
- Not shown publicly
- We show a dash rather than guess
- Observed frequency
- Monthly or less
- From 1 post indexed in the last 90 days
- Last post
- Oct 30, 2026
- 16 days ago
- Likely audience
- biotech founders
- Inferred from post content
Integral Developments is a Substack newsletter by Egan Peltan covering AI in drug discovery, frontier AI labs biotech acquisitions and human-AI collaboration in physical-world productivity. NewsletterFIT indexed 1 post from it in the last 90 days, most recently on Oct 30, 2026.
Topics
- AI in drug discovery
- frontier AI labs biotech acquisitions
- human-AI collaboration in physical-world productivity
- pharmaceutical development timelines
- validation of therapeutic hypotheses
Recent posts
- Pipeline-in-a-Person will…
- LLM-enabled pandemics…
- Part 5:…
- Part 4:…
- Part 3:…
Sponsors detected
No sponsored posts detected in the last 180 days of indexed posts.
Detected automatically from posts marked as sponsored. Detection can miss or misread placements.
See the full picture on Integral Developments
Subscriber momentum over time, every detected sponsor with the source post, companies and people it mentions, guests, and an alert when any of it changes.
Integral Developments alternatives: similar newsletters
Ranked by how many topics they share with Integral Developments.
- Decoding Bio14K subscribers
SubstackWeekly · last post 3 days ago
Likely audience: Bioinformatics researchers
1 shared topic
- Where Tech Meets Bio12K subscribers
SubstackWeekly · last post 4 days ago
Likely audience: Venture capitalists
1 shared topic
- Biotech Blueprint7K subscribers
SubstackEvery two weeks · last post 16 days ago
Likely audience: Biotech investors
1 shared topic
- Deep Phenotype, a Substack by insitro 2K subscribers
SubstackMonthly or less · last post Aug 28, 2026
Likely audience: Science researchers
1 shared topic
LinkedInEvery two weeks · last post 32 days ago
Likely audience: life sciences executives
1 shared topic
LinkedInEvery two weeks · last post 26 days ago
Likely audience: Pharmaceutical executives
1 shared topic
Compiled from public pages · refreshed Nov 8, 2026 · How NewsletterFIT collects and labels data
